| Value | ₹80.08 Cr |
|---|
BSE filing, BSE: 544442. Summary written from the filing by ALFA Finder's alert engine.
Chemkart India Ltd: key numbers
- Share price
- ₹255.85
- Market cap
- ₹309.6 Cr
- Revenue (annual)
- ₹214.8 Cr
- Net profit (annual)
- ₹19.66 Cr
- P/E (TTM)
- 15.8×Sector 38.6×
- Promoter holding
- 74.88%
- FII holding
- 0.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chemkart India Ltd
All →Chemkart India Investor Presentation: Key Takeaways
H1 FY27 consolidated revenue ₹205.9 Cr (+99.4% YoY), EBITDA ₹29.4 Cr (14.3% margin), PAT ₹22.6 Cr (11.0%). EZRM SEZ CDMO facility under construction.
Chemkart India Other Announcement
Chemkart India reported no IPO fund deviation for the half year ended 30 September 2026. Rs.39.48 Crore of Rs.64.47 Crore allocation is utilised.
Chemkart India H1 FY27 Results: Net Profit ₹22.6 Cr, Up 121.6% YoY
Chemkart India Ltd reported revenue from operations of ₹205.9 Cr (+99.5% YoY) and net profit of ₹22.6 Cr (+121.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹22.6 Cr · +121.6% YoY
Chemkart India Acquisition Worth ₹0.98 Cr
Chemkart invests Rs. 0.98 Crore in its WOS Easy Raw Materials for working capital. The related-party transaction was approved at arm's length on 27 October 2026.
- Value
- ₹0.98 Cr
Chemkart India Capital Structure Change
Chemkart India invests Rs. 0.98 Crore in its wholly-owned subsidiary Easy Raw Materials via a rights issue. The funds support commissioning of the subsidiary's manufacturing unit.
- Value
- ₹0.98 Cr
Chemkart India Other Announcement
Chemkart India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. The disclosure provides details of shareholder categories and promoter holdings.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.